ATZ11 Recognizes Not Only Z-α1-Antitrypsin-Polymers and Complexed Forms of Non-Z-α1-Antitrypsin but Also the von Willebrand Factor

ATZ11 Recognizes Not Only Z-α1-Antitrypsin-Polymers and Complexed Forms of Non-Z-α1-Antitrypsin but Also the von Willebrand Factor

Bibliographic Details
Main Authors:	Goltz, Diane, Hittetiya, Kanishka, Yadegari, Hamideh, Driesen, Julia, Kirfel, Jutta, Neuhaus, Thomas, Steiner, Susanne, Esch, Christiane, Bedorf, Jörg, Hertfelder, Hans-Jörg, Fischer, Hans-Peter
Format:	Online
Language:	English
Published:	Public Library of Science 2014
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3960128/

Similar Items

Molecular Mechanism of Z α1-Antitrypsin Deficiency*
by: Huang, Xin, et al.
Published: (2016)

The Z Mutation Alters the Global Structural Dynamics of α1-Antitrypsin
by: Hughes, Victoria A., et al.
Published: (2014)

Discovery of an Inhibitor of Z-Alpha1 Antitrypsin Polymerization
by: Berthelier, Valerie, et al.
Published: (2015)

Prevalence of PI*Z and PI*S alleles of alpha-1-antitrypsin deficiency in Finland
by: Häggblom, Jan, et al.
Published: (2015)

Role of Drosophila EDEMs in the degradation of the alpha-1-antitrypsin Z variant
by: JANG, BO-YUN, et al.
Published: (2015)

Increased ERK signalling promotes inflammatory signalling in primary airway epithelial cells expressing Z α1-antitrypsin
by: van ‘t Wout, Emily F.A., et al.
Published: (2014)

The endoplasmic reticulum remains functionally connected by vesicular transport after its fragmentation in cells expressing Z-α1-antitrypsin
by: Dickens, Jennifer A., et al.
Published: (2016)

Appropriateness of Newborn Screening for α1-Antitrypsin Deficiency
by: Teckman, Jeffrey, et al.
Published: (2014)

Ruptured Gastric Aneurysm in α-1 Antitrypsin Deficiency
by: Jaruvongvanich, Veeravich, et al.
Published: (2016)

NorUDCA promotes degradation of α1-antitrypsin mutant Z protein by inducing autophagy through AMPK/ULK1 pathway.
by: Youcai Tang, et al.

A single-chain variable fragment intrabody prevents intracellular polymerization of Z α1-antitrypsin while allowing its antiproteinase activity
by: Ordóñez, Adriana, et al.
Published: (2015)

Prevalence of α-1-Antitrypsin Gene Mutations in Saudi Arabia
by: Aljarallah, Badr, et al.
Published: (2011)

Therapeutic target-site variability in α1-antitrypsin characterized at high resolution
by: Patschull, Anathe O. M., et al.
Published: (2011)

Stem cell-based therapy for α1-antitrypsin deficiency
by: Rashid, S Tamir, et al.
Published: (2012)

In Silico Assessment of Potential Druggable Pockets on the Surface of α1-Antitrypsin Conformers
by: Patschull, Anathe O. M., et al.
Published: (2012)

Deficiency of α-1-antitrypsin influences systemic iron homeostasis
by: Ghio, Andrew J, et al.
Published: (2013)

Context-Specific and Immune Cell-Dependent Antitumor Activities of α1-Antitrypsin
by: Guttman, Ofer, et al.
Published: (2016)

T Helper Subsets, Peripheral Plasticity, and the Acute Phase Protein, α1-Antitrypsin
by: Baranovski, Boris M., et al.
Published: (2015)

Activity of cathepsin D and α1-antitrypsin in blood of men with malignant melanoma
by: Kuźniewski, Rafał
Published: (2014)

Correction: Short-term variability of biomarkers of proteinase activity in patients with emphysema associated with type Z alpha-1-antitrypsin deficiency
by: Stolk, Jan, et al.
Published: (2006)

Short-term variability of biomarkers of proteinase activity in patients with emphysema associated with type Z alpha-1-antitrypsin deficiency
by: Stolk, Jan, et al.
Published: (2005)

Quantitation of circulating wild-type alpha-1-antitrypsin in heterozygous carriers of the S and Z deficiency alleles
by: Donato, L. J., et al.
Published: (2015)

The role of bronchial epithelial cells in the pathogenesis of COPD in Z-alpha-1 antitrypsin deficiency
by: Pini, Laura, et al.
Published: (2014)

Cardiovascular risk in patients with alpha-1-antitrypsin deficiency
by: Sebastian Fähndrich, et al.
Published: (2017-09-01)

Safety and efficacy of alpha-1-antitrypsin augmentation therapy in the treatment of patients with alpha-1-antitrypsin deficiency
by: Petrache, Irina, et al.
Published: (2009)

Mineralization of alpha-1-antitrypsin inclusion bodies in Mmalton alpha-1-antitrypsin deficiency
by: Francesco Callea, et al.
Published: (2018-05-01)

The prevalence of alpha-1 antitrypsin deficiency in Ireland
by: Carroll, Tomás P, et al.
Published: (2011)

Alpha 1-antitrypsin and survival in hepatocellular carcinoma.
by: Tzonou, A., et al.
Published: (1990)

Alpha 1-antitrypsin retention in an ectopic liver
by: Dettmer, Matthias, et al.
Published: (2011)

alpha1-Antitrypsin deficiency and hepatocellular cancer.
by: Kew, M. C., et al.
Published: (1978)

THE NATURE OF SERUM ANTITRYPSIN : STUDIES ON FERMENT ACTION. XIII.
by: Jobling, James W., et al.
Published: (1914)

alpha 1-Antitrypsin deficiency and susceptibility to lung disease.
by: Evans, H E, et al.
Published: (1979)

Alpha-1-Antitrypsin in Pathogenesis of Hepatocellular Carcinoma
by: Topic, Aleksandra, et al.
Published: (2012)

Alpha 1 Antitrypsin Deficiency in Infants with Neonatal Cholestasis
by: Monajemzadeh, Maryam, et al.
Published: (2013)

Alpha 1-antitrypsin and its involvement in reumatoid arthritis
by: Nur Munawwarah
Published: (2014)

Identification of a novel alpha1-antitrypsin variant
by: de Seynes, Camille, et al.
Published: (2016)

Alpha-1 antitrypsin genotypes in breast cancer patients
by: El-Akawi, Z, et al.
Published: (2005)

Alpha-1 Antitrypsin Deficiency PI*Z and PI*S Gene Frequency Distribution Using on Maps of the World by an Inverse Distance Weighting (IDW) Multivariate Interpolation Method
by: Blanco, Ignacio, et al.
Published: (2012)

Crystallographic and Cellular Characterisation of Two Mechanisms Stabilising the Native Fold of α1-Antitrypsin: Implications for Disease and Drug Design
by: Gooptu, Bibek, et al.
Published: (2009)

Prolastin, a pharmaceutical preparation of purified human α1-antitrypsin, blocks endotoxin-mediated cytokine release
by: Nita, Izabela, et al.
Published: (2005)